NDC 67296-2335-03 - oxybutynin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67296-2335
- Requested NDC
- 67296-2335-03
- Package NDCs from labels
- 67296-2335-3, 67296-2335-03
- Manufacturer
- Redpharm Drug
- Effective date
- 2026-09-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| oxybutynin - Redpharm Drug | Redpharm Drug | 2026-09-12 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | TruPharma LLC | 7c497c6c-2448-2c80-e053-2991aa0ab8c7 | 2026-07-27 | Warnings, Adverse reactions | L9F3D9RENQ |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ATLANTIC BIOLOGICALS CORP. | fe4ed76b-0009-455f-be30-47e80fc1afdf | 2026-07-09 | Warnings, Adverse reactions | L9F3D9RENQ |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 55f618d1-4463-3200-e063-6394a90a89a8 | 2026-07-06 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | 9ede5def-d185-4e40-9c10-8663ac654caf | 2026-07-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | American Health Packaging | 0c71bdfb-01db-49ac-a8e9-0037df0d24af | 2026-06-24 | Warnings, Adverse reactions | 863636 863619 L9F3D9RENQ |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | 3NXW29V3WO FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | 3NXW29V3WO FZ989GH94E |
| Rohto Digi-Eye | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE | The Mentholatum Company | 5d6f37b9-b568-4cb6-92de-eb40779f3f8c | 2026-06-03 | Warnings | 3NXW29V3WO |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | ac10c7b7-d0cb-4068-93e2-c0e51f15866e | 2026-06-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| EELHOE Cuticle Pusher Pen | GLYCERIN | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 52c7f956-a2a1-ae1d-e063-6294a90ab3c2 | 2026-05-27 | Warnings | ZF94AP8MEY |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 73d715dc-868d-4194-b668-4c39ababa698 | 2026-05-20 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | a5965c8b-179d-4665-8a3b-324b693607ee | 2026-05-19 | Warnings, Adverse reactions | 863619 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 7db4ab81-b379-4a6d-b469-95eb9e184b56 | 2026-05-14 | Warnings, Adverse reactions | 863636 L9F3D9RENQ |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | FZ989GH94E |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | American Health Packaging | 4574b227-9726-4798-bac2-83bfb9616f09 | 2026-04-16 | Warnings, Adverse reactions | L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.